Exelixis

Exelixis is an oncology-focused biotech company innovating cancer treatments for life. The company is dedicated to giving more patients hope for the future through novel therapeutic approaches.

Source: https://www.exelixis.com/

cabozantinibCabometyx

multi-kinase inhibitor

Cabozantinib is an oral multi-kinase inhibitor that blocks MET, VEGF receptors and RET, pathways tumours use to grow and build blood supply. As Cabometyx it is used in advanced kidney and liver cancer and thyroid cancer; as Cometriq, in medullary thyroid carcinoma.

Cancer cells rely on signalling proteins called receptor tyrosine kinases to grow and to recruit blood vessels. Cabozantinib blocks several of these r

1 medicine explained